Mirabegron: a safety review

Author： Tyagi Pradeep   Tyagi Vikas   Chancellor Michael  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.10, Iss.2, 2011-03, pp. : 287-294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I results support ocular safety of mirabegron

By  

Reactions Weekly, Vol. 1, Iss. 1394, 2012-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Mirabegron in the treatment of overactive bladder

By Leone Roberti Maggiore Umberto   Cardozo Linda   Ferrero Simone   Sileo Filomena   Cola Alice   Torella Marco   Colacurci Nicola   Candiani Massimo   Salvatore Stefano  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 6, 2014-04 ,pp. : 873-887

Informa Healthcare

Access to resources Recommend Favorite

Safety of mirtazapine: a review

By Montgomery S.A.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 263-264

Elsevier

Access to resources Recommend Favorite

Zanamivir: A Review of Clinical Safety

By Freund B.  

Drug Safety, Vol. 21, Iss. 4, 1999-10 ,pp. : 267-281

Adis International

Access to resources Recommend Favorite

A review of the safety and tolerability of aripiprazole

By Pae Chi-Un  

Expert Opinion on Drug Safety, Vol. 8, Iss. 3, 2009-05 ,pp. : 373-386

Informa Healthcare

Access to resources Recommend Favorite